Cancer Biological Therapy Market Report

Global and Region Cancer Biological Therapy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：226
  • REPORT CODE：GMM1017557
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies. North America dominates a major share of the global Cancer Biological Therapy market

    On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc.

    The report details the trend, potential and market size of Cancer Biological Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Biological Therapymarket, defines the market attractiveness level of Cancer Biological Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Biological Therapy industry, describes the types of Cancer Biological Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Biological Therapy market and the development prospects and opportunities of Cancer Biological Therapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Biological Therapy market in Chapter 13.

    By Player:

    • Pfizer

    • AstraZeneca, Plc

    • Amgen

    • GlaxoSmithKline

    • ELI Lilly

    • Sanofi

    • Bayer

    • Abbvie

    • Takeda Pharmaceuticals

    • Spectrum Pharmaceuticals

    • Otsuka

    • Celgene Corporation

    • Merck

    • Novartis International

    • Roche

    • Incyte

    • Bristol-Myers Squibb

    • Seattle Genetics

    • Eisai

    By Type:

    • Monoclonal Antibodies

    • Vaccines

    • Cancer Growth Blockers

    • Blood Cell Growth Factors

    By End-User:

    • Hospitals

    • Diagnostic Laboratories

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Biological Therapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Biological Therapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Biological Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Biological Therapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Biological Therapy Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Biological Therapy Consumption (2017-2022)

    • 7.2 United States Cancer Biological Therapy Consumption (2017-2022)

    • 7.3 Europe Cancer Biological Therapy Consumption (2017-2022)

    • 7.4 China Cancer Biological Therapy Consumption (2017-2022)

    • 7.5 Japan Cancer Biological Therapy Consumption (2017-2022)

    • 7.6 India Cancer Biological Therapy Consumption (2017-2022)

    • 7.7 South Korea Cancer Biological Therapy Consumption (2017-2022)

    8 Region and Country-wise Cancer Biological Therapy Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.4 China Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.6 India Cancer Biological Therapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Biological Therapy Consumption Forecast (2022-2028)

    9 Global Cancer Biological Therapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Biological Therapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cancer Growth Blockers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Blood Cell Growth Factors Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Biological Therapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    10 Global Cancer Biological Therapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Biological Therapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cancer Growth Blockers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Blood Cell Growth Factors Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Biological Therapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Biological Therapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Biological Therapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Biological Therapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Biological Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Biological Therapy Market Competitive Analysis

    • 14.1 Pfizer

      • 14.1.1 Pfizer Company Details

      • 14.1.2 Pfizer Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Cancer Biological Therapy Product and Service

    • 14.2 AstraZeneca, Plc

      • 14.2.1 AstraZeneca, Plc Company Details

      • 14.2.2 AstraZeneca, Plc Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca, Plc Cancer Biological Therapy Product and Service

    • 14.3 Amgen

      • 14.3.1 Amgen Company Details

      • 14.3.2 Amgen Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen Cancer Biological Therapy Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Cancer Biological Therapy Product and Service

    • 14.5 ELI Lilly

      • 14.5.1 ELI Lilly Company Details

      • 14.5.2 ELI Lilly Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 ELI Lilly Cancer Biological Therapy Product and Service

    • 14.6 Sanofi

      • 14.6.1 Sanofi Company Details

      • 14.6.2 Sanofi Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sanofi Cancer Biological Therapy Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Cancer Biological Therapy Product and Service

    • 14.8 Abbvie

      • 14.8.1 Abbvie Company Details

      • 14.8.2 Abbvie Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abbvie Cancer Biological Therapy Product and Service

    • 14.9 Takeda Pharmaceuticals

      • 14.9.1 Takeda Pharmaceuticals Company Details

      • 14.9.2 Takeda Pharmaceuticals Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Takeda Pharmaceuticals Cancer Biological Therapy Product and Service

    • 14.10 Spectrum Pharmaceuticals

      • 14.10.1 Spectrum Pharmaceuticals Company Details

      • 14.10.2 Spectrum Pharmaceuticals Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Spectrum Pharmaceuticals Cancer Biological Therapy Product and Service

    • 14.11 Otsuka

      • 14.11.1 Otsuka Company Details

      • 14.11.2 Otsuka Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Otsuka Cancer Biological Therapy Product and Service

    • 14.12 Celgene Corporation

      • 14.12.1 Celgene Corporation Company Details

      • 14.12.2 Celgene Corporation Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Celgene Corporation Cancer Biological Therapy Product and Service

    • 14.13 Merck

      • 14.13.1 Merck Company Details

      • 14.13.2 Merck Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Merck Cancer Biological Therapy Product and Service

    • 14.14 Novartis International

      • 14.14.1 Novartis International Company Details

      • 14.14.2 Novartis International Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Novartis International Cancer Biological Therapy Product and Service

    • 14.15 Roche

      • 14.15.1 Roche Company Details

      • 14.15.2 Roche Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Roche Cancer Biological Therapy Product and Service

    • 14.16 Incyte

      • 14.16.1 Incyte Company Details

      • 14.16.2 Incyte Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Incyte Cancer Biological Therapy Product and Service

    • 14.17 Bristol-Myers Squibb

      • 14.17.1 Bristol-Myers Squibb Company Details

      • 14.17.2 Bristol-Myers Squibb Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Bristol-Myers Squibb Cancer Biological Therapy Product and Service

    • 14.18 Seattle Genetics

      • 14.18.1 Seattle Genetics Company Details

      • 14.18.2 Seattle Genetics Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Seattle Genetics Cancer Biological Therapy Product and Service

    • 14.19 Eisai

      • 14.19.1 Eisai Company Details

      • 14.19.2 Eisai Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Eisai Cancer Biological Therapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Biological Therapy

    • Figure Cancer Biological Therapy Picture

    • Table Global Cancer Biological Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Biological Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Biological Therapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Biological Therapy Consumption by Country (2017-2022)

    • Figure United States Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Biological Therapy Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Growth Blockers Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cell Growth Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Research & Academic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Growth Blockers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cell Growth Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research & Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Biological Therapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Biological Therapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Cancer Biological Therapy Product and Service

    • Table AstraZeneca, Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca, Plc Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca, Plc Cancer Biological Therapy Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Cancer Biological Therapy Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Cancer Biological Therapy Product and Service

    • Table ELI Lilly (Foundation Year, Company Profile and etc.)

    • Table ELI Lilly Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table ELI Lilly Cancer Biological Therapy Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cancer Biological Therapy Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Cancer Biological Therapy Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Cancer Biological Therapy Product and Service

    • Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceuticals Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceuticals Cancer Biological Therapy Product and Service

    • Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Spectrum Pharmaceuticals Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Cancer Biological Therapy Product and Service

    • Table Otsuka (Foundation Year, Company Profile and etc.)

    • Table Otsuka Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Cancer Biological Therapy Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Cancer Biological Therapy Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Cancer Biological Therapy Product and Service

    • Table Novartis International (Foundation Year, Company Profile and etc.)

    • Table Novartis International Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International Cancer Biological Therapy Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Cancer Biological Therapy Product and Service

    • Table Incyte (Foundation Year, Company Profile and etc.)

    • Table Incyte Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Incyte Cancer Biological Therapy Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Cancer Biological Therapy Product and Service

    • Table Seattle Genetics (Foundation Year, Company Profile and etc.)

    • Table Seattle Genetics Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seattle Genetics Cancer Biological Therapy Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Cancer Biological Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Cancer Biological Therapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US